These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 16473430)
1. Development of an oral sustained release drug delivery system utilizing pH-dependent swelling of carboxyvinyl polymer. Nakamura K; Nara E; Akiyama Y J Control Release; 2006 Apr; 111(3):309-15. PubMed ID: 16473430 [TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride. Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs. Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147 [TBL] [Abstract][Full Text] [Related]
6. Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon. Krishnamachari Y; Madan P; Lin S Int J Pharm; 2007 Jun; 338(1-2):238-47. PubMed ID: 17368982 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmaceutical properties of sustained-release gel beads prepared by alginate having different molecular size with commercial sustained-release tablet. Imai T; Kawasaki C; Nishiyama T; Otagiri M Pharmazie; 2000 Mar; 55(3):218-22. PubMed ID: 10756544 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets. Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278 [TBL] [Abstract][Full Text] [Related]
9. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat SR 30 D and the enteric polymer dispersion Kollicoat MAE 30 DP. Dashevsky A; Kolter K; Bodmeier R Eur J Pharm Biopharm; 2004 Jul; 58(1):45-9. PubMed ID: 15207536 [TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability. Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837 [TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of a new sustained-release formulation of morphine. Araico A; Saadeddin A; Torres-Molina F; Peris JE Pharmazie; 2009 Oct; 64(10):653-5. PubMed ID: 19947167 [TBL] [Abstract][Full Text] [Related]
12. Colon-specific delivery tablets of sodium 4-aminosalicylic acid. Li Y; Li HJ; Yang GR; Gu WP; Ma YK; Zhang MH; Sun J; Sun SJ Yao Xue Xue Bao; 2006 Oct; 41(10):927-32. PubMed ID: 17184108 [TBL] [Abstract][Full Text] [Related]
13. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine (II): in vivo evaluation. Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ibuki R; Higaki K; Kimura T J Control Release; 2006 May; 112(1):51-6. PubMed ID: 16545477 [TBL] [Abstract][Full Text] [Related]
14. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery. Kaur K; Kim K Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342 [TBL] [Abstract][Full Text] [Related]
15. Controlled delivery achieved with bi-layer matrix devices produced by co-injection moulding. Vaz CM; van Doeveren PF; Dias GR; Reis RL; Cunha AM Macromol Biosci; 2004 Aug; 4(8):795-801. PubMed ID: 15468273 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of guar gum-based three-layer matrix tablets for oral controlled delivery of highly soluble metoprolol tartrate as a model drug. Al-Saidan SM; Krishnaiah YS; Satyanarayana V; Bhaskar P; Karthikeyan RS Eur J Pharm Biopharm; 2004 Nov; 58(3):697-703. PubMed ID: 15451547 [TBL] [Abstract][Full Text] [Related]
17. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis. Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794 [TBL] [Abstract][Full Text] [Related]
18. Permeability and swelling studies on free films containing inulin in combination with different polymethacrylates aimed for colonic drug delivery. Akhgari A; Farahmand F; Afrasiabi Garekani H; Sadeghi F; Vandamme TF Eur J Pharm Sci; 2006 Jul; 28(4):307-14. PubMed ID: 16713201 [TBL] [Abstract][Full Text] [Related]
19. Predictable pulsatile release of tramadol hydrochloride for chronotherapeutics of arthritis. Dabhi C; Randale S; Belgamwar V; Gattani S; Tekade A Drug Deliv; 2010 Jul; 17(5):273-81. PubMed ID: 20524906 [TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of a novel pH- and time-based multiunit colonic drug delivery system. Bott C; Rudolph MW; Schneider AR; Schirrmacher S; Skalsky B; Petereit HU; Langguth P; Dressman JB; Stein J Aliment Pharmacol Ther; 2004 Aug; 20(3):347-53. PubMed ID: 15274672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]